Dornase Alfa
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Dornase Alfa and Cisplatin in Refractory Germ Cell Cancer. (NCT07121322) | National Cancer Institute, Slovakia | 2025-07-30 |
Track Dornase Alfa automatically
Every clearance here is in the API, with alerts when new ones post.